- <![CDATA[Track the Lung Cancer Abstracts That are Gaining Attention at ASCO 2026]]><![CDATA[Read on to see what data are poised to shape clinical discussions and decision-making in lung cancer at 2026 ASCO Annual Meeting in Chicago, Illinois.]]>onclive · 2mo ago↗ source
- <![CDATA[EGFR-Targeted Therapy Sequencing After Resistance in NSCLC]]><![CDATA[Learn how clinicians tackle EGFR lung cancer resistance—using NGS, radiation, chemo, amivantamab, and ADCs to tailor next-line therapy.]]>onclive · 2mo ago↗ source
- <![CDATA[HERIZON-GEA-01 Study Design, Geographic Distribution, and PD-L1 Testing Considerations]]><![CDATA[Experts debate PD‑L1 testing in HER2+ metastatic gastric cancer as new trial data reshapes when to add immunotherapy.]]>onclive